biomed devic servic
price close busi januari
develop manufactur market
devic instrument orthoped
specialti
continu view compel asset large-cap med-tech believ
core posit growth-ori investor given view stable/
improv market fundament robust new product cycl opportun
durabl oper leverag continu share-tak orthoped note
increas investor concern regard pend acquisit link
previou note particularli around potenti dis-synergi overlap
lower extrem products/distribut expect dilut
deal thesi deliv upsid guidanc remain intact
compani continu take market share across board benefit
meaning halo effect mako placement improv capit equip
market someth expect continue/acceler buy maintain pt
recap deliv solid result came cg/street
expect specif sale y/ organ
cg/street estim strength driven
momentum across entir portfolio particularli knee ahead
estim continu trend posit given robust system placement
earli launch mako japan fact growth remain robust
despit competit launch past sever quarter
revenu detail report sale growth organ
support us sale growth intern sale growth
xfx orthoped grew xfx strong perform knee
xfx hip xfx off-set weak trauma
extrem xfx compar expect medsurg also
saw continu strong growth xfx driven strength endoscopi
xfx though medic slightli softer
expect xfx vs estim neurotech
impress xfx manag note strong demand stroke
neuro instrument product spine weak spot rel estim
post growth compar estim manag note
execut improv restor confid q/q improv
mako place mako system ww y/i includ us
bring total ww instal base close system us
mako procedur us exceed bring total year
total knee procedur y/i compani provid
specif number hip procedur note y/i growth rate
encourag addit manag note robust order book consist
sale cycl lack competit pressur note place mako
low dd percentag us ortho hospit demonstr earli natur
opportun potenti continu momentum earli
clinic data begin trickl year manag highlight intern
opportun next major driver mako growth especi japan
compani recent receiv approv partial knee procedur addit total
knee hip robot instal regard spine upper extrem
applic manag continu keep futur detail close vest state
still priorit note recent mobius/cardan pend wright
medic acquisit provid foundat build spine extrem
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object
view compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
